GTHX (G1 Therapeutics, Inc.) Net earnings per share growth this year

GTHX (G1 Therapeutics, Inc.) - company brandmark

Geopolitical instability is limiting the export of oncology drugs and access to raw materials, which is confirmed by the comparison of annual EPS growth, where the latest parameter stands at 59.20. G1 Therapeutics, Inc. (GTHX) revenues are based on the sale of COSELA for bone marrow protection. Management's current course toward increasing royalty payments creates a foundation for further growth in earnings per share.

Earnings per share growth in current year: G1 Therapeutics Inc. (GTHX) for 07/04/2022 - 09/28/2024

Financial and market metric breakdowns for G1 Therapeutics Inc. (GTHX)

Summary company analysis:GTHX G1 Therapeutics
Signature product of G1 Therapeutics

G1 Therapeutics, Inc. (GTHX) develops specialized oncology drugs, integrating strict ESG standards and environmental optimization into its production cycles. By analyzing the annual dynamics of net income per share, an investor can see the impact of these operating expenses on the business's real yield in real-time. This indicator measures the rate of change in EPS relative to the previous year, allowing one to detect a trend reversal in time and avoid purchasing an overvalued asset.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year herontx.com|NVCT: Earnings growth in current year|Net earnings per share change in current year Coherus CHRS|Net earnings per share growth this year CRBP|Earnings per share growth rate in current year Cardiff Oncology CRDF|Net earnings per share growth this year BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Earnings per share increase in current year|Lixte Biotechnology - Net earnings per share growth this year|Net earnings per one share growth for the current year CTXR (Citius Pharma)|Cellectar - Earnings growth in current year|Earnings per share increase in current year BLRX (BioLineRx Corp)|CANF: Earnings growth in current year|Earnings per share growth rate in current year Aprea (APRE)|Earnings per share growth in current year kaziatherapeutics.com|SLXN: Earnings per share increase in current year|Earnings growth in current year NCNA|Earnings growth in current year Chimerix Inc (CMRX)|Earnings per share growth in current year Cyclacel Pharmaceuticals Inc. CYCC|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year